Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

ADVM holding history

Adverum Biotechnologies, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ADVM by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−184,762−100.0%Sold outHolders
Q3 2025184,762$837.3K<0.1%00.0%UnchangedHolders
Q2 2025184,762$397.4K<0.1%−266,496−59.1%ReducedHolders
Q1 2025451,258$1.97M<0.1%+8,768+2.0%AddedHolders
Q4 2024442,490$2.07M<0.1%+3,434+0.8%AddedHolders
Q3 2024439,056$3.08M<0.1%−16,731−3.7%ReducedHolders
Q2 2024455,787$3.13M<0.1%+262,271+135.5%AddedHolders
Q1 2024193,516$2.74M<0.1%+107,095+123.9%AddedConverted for a 1-for-10 splitHolders
Q4 2023864,206$650.7K<0.1%00.0%UnchangedHolders
Q3 2023864,206$1.30M<0.1%−22,840−2.6%ReducedHolders
Q2 2023887,046$1.41M<0.1%+99,146+12.6%AddedHolders
Q1 2023787,900$565.2K<0.1%+15,748+2.0%AddedHolders
Q4 2022772,152$447.0K<0.1%+16,563+2.2%AddedHolders
Q3 2022755,589$717.0K<0.1%+2,587+0.3%AddedHolders
Q2 2022753,002$903.0K<0.1%−672,640−47.2%ReducedHolders
Q1 20221,425,642$1.87M<0.1%−151,884−9.6%ReducedHolders
Q4 20211,577,526$2.78M<0.1%+43,597+2.8%AddedHolders
Q3 20211,533,929$3.33M<0.1%−66,759−4.2%ReducedHolders
Q2 20211,600,688$5.60M<0.1%+97,016+6.5%AddedHolders
Q1 20211,503,672$14.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.